FAIRCHEMOR Fairchem Organics Q4 FY25 results (Jan–Mar 2025) and concall
Fairchem Organics reported Q4 FY25 revenue of ₹121 crores, up 6.3% QoQ, but EBITDA margins compressed to 3.64% due to a 22% additional custom duty on a key raw material and pricing pressure from Chinese competitors. Despite these challenges, the company achieved over 11% volume growth QoQ and is making progress on its high-value Isostearic acid product, securing 16 customer approvals. New product development is underway, with equipment expected by December 2025 and trials starting in early 2026, utilizing 40,000 tons of earmarked capacity.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 | Q4 FY25 |
|---|---|---|
| Revenue | 114 | 121 |
| EBITDA | 8 | 4 |
| Net profit | 4 | 1 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
